1431957-73-1
1431957-73-1
Chemical Structure
FTISADTSK
- CAS No.: 1431957-73-1
- Formula:C42H68N10O16
- Molecular Weight:969.05
InChIKey: RWCAPLOZSLPNEV-BNFYKCPDSA-N
SMILES: O=C(N[C@@H](CO)C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@H](C(O)=O)CCCCN)=O)=O)=O)=O)=O)[C@H]([C@@H](C)CC)NC([C@H]([C@H](O)C)NC([C@@H](N)CC1=CC=CC=C1)=O)=O
Biological Activity: FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
FTISADTSK | FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
FTISADTSK-13C 6,15N2(TFA) | 96.04% | FTISADTSK-13C6,15N2 TFA is 13C- and 15N-labeled FTISADTSK (HY-P3146). FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
